Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Oncology Reports
|
December 22, 1999
In vivo efficacy and pharmacokinetics of a new hypoxic cell radiosensitizer doranidazole in SUIT-2 human pancreatic cancer xenografted in mouse pancreas
H Matsuoka, Y Shibamoto, T Kubota, et al.
General Pharmacology
|
May 1, 1992
Endothelium-dependent vasodilation by LP-805, a novel vasodilating agent, on rat thoracic aorta
K Kishii, T Morimoto, N Nakajima, et al.
General Pharmacology
|
May 1, 1992
Effects of LP-805, a new vasodilating agent, on cytosolic Ca2+ and contraction in vascular smooth muscle of rat aorta
K Kishii, M Inazu, T Morimoto, et al.
General Pharmacology
|
May 1, 1992
Effects of LP-805, a new vasodilating agent, on rat thoracic aorta
K Kishii, M Inazu, T Morimoto, et al.
European Journal of Pharmacology
|
November 5, 1991
Attenuation of ischemia-induced regional myocardial acidosis by LP-805, a newly developed vasodilator, in dogs
K Ichihara, T Morimoto, T Shiba, et al.
General Pharmacology
|
May 1, 1992
Effects of LP-805, a novel vasorelaxant agent, a potassium channel opener, on rat thoracic aorta
K Kishii, T Morimoto, N Nakajima, et al.
International Journal of Radiation Biology
|
May 22, 2002
Hypoxia and etanidazole alter radiation-induced apoptosis in HL60 cells but not in MOLT-4 cells
O Inanami, K Sugihara, T Okui, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
May 24, 2005
Post-irradiation hypoxic incubation of X-irradiated MOLT-4 cells reduces apoptotic cell death by changing the intracellular redox state and modulating SAPK/JNK pathways
T Hamasu, O Inanami, M Tsujitani, et al.
Scientific Reports
|
February 15, 2017
Geosmin-producing Species of Coelosphaerium (Synechococcales, Cyanobacteria) in Lake Shinji, Japan
T Godo, Y Saki, Y Nojiri, et al.
Anti-Cancer Drugs
|
March 29, 2001
Phase Ia study of a hypoxic cell sensitizer doranidazole (PR-350) in combination with conventional radiotherapy
K Nemoto, Y Shibamoto, J Ohmagari, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Oncology Reports
|
December 22, 1999
In vivo efficacy and pharmacokinetics of a new hypoxic cell radiosensitizer doranidazole in SUIT-2 human pancreatic cancer xenografted in mouse pancreas
H Matsuoka, Y Shibamoto, T Kubota, et al.
General Pharmacology
|
May 1, 1992
Endothelium-dependent vasodilation by LP-805, a novel vasodilating agent, on rat thoracic aorta
K Kishii, T Morimoto, N Nakajima, et al.
General Pharmacology
|
May 1, 1992
Effects of LP-805, a new vasodilating agent, on cytosolic Ca2+ and contraction in vascular smooth muscle of rat aorta
K Kishii, M Inazu, T Morimoto, et al.
General Pharmacology
|
May 1, 1992
Effects of LP-805, a new vasodilating agent, on rat thoracic aorta
K Kishii, M Inazu, T Morimoto, et al.
European Journal of Pharmacology
|
November 5, 1991
Attenuation of ischemia-induced regional myocardial acidosis by LP-805, a newly developed vasodilator, in dogs
K Ichihara, T Morimoto, T Shiba, et al.
General Pharmacology
|
May 1, 1992
Effects of LP-805, a novel vasorelaxant agent, a potassium channel opener, on rat thoracic aorta
K Kishii, T Morimoto, N Nakajima, et al.
International Journal of Radiation Biology
|
May 22, 2002
Hypoxia and etanidazole alter radiation-induced apoptosis in HL60 cells but not in MOLT-4 cells
O Inanami, K Sugihara, T Okui, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
May 24, 2005
Post-irradiation hypoxic incubation of X-irradiated MOLT-4 cells reduces apoptotic cell death by changing the intracellular redox state and modulating SAPK/JNK pathways
T Hamasu, O Inanami, M Tsujitani, et al.
Scientific Reports
|
February 15, 2017
Geosmin-producing Species of Coelosphaerium (Synechococcales, Cyanobacteria) in Lake Shinji, Japan
T Godo, Y Saki, Y Nojiri, et al.
Anti-Cancer Drugs
|
March 29, 2001
Phase Ia study of a hypoxic cell sensitizer doranidazole (PR-350) in combination with conventional radiotherapy
K Nemoto, Y Shibamoto, J Ohmagari, et al.
Page
of 2